At a transformative time in medicine, as wearables and interactive smartphone apps rapidly expand access to assessment and treatment beyond clinical settings, Geisel School of Medicine’s Center for Technology and Behavioral Health (CTBH) hosted its fifth annual Digital Health Summit at Dartmouth on Oct. 21.
Articles by: Geisel Communications
Opinion: Dartmouth Health Urges Investment in Youth Mental Health in New Hampshire—NH Business Review
Read article—William Torrey, chair of psychiatry, and Jennifer McLaren, a professor ofpsychiatry, co-authored an opinion piece calling for continued investment in youth mental health services in New Hampshire. They highlight Dartmouth Health’s expansion of inpatient and outpatient psychiatric care for young people and urge the state to build on recent improvements in youth mental health outcomes.
Less Than 5% of Young Women With Cancer Receive Fertility Preservation Support—Healio
Read article—Erika Moen, an associate professor of biomedical data science, is quoted in an article about research finding that just 3.4% of young women diagnosed with cancer received fertility preservation support, despite a substantial increase in services over the past decade. “It’s important that women are aware of the availability of these services,” Moen said.
Dartmouth Cancer Center Director Roy S. Herbst Elected to National Academy of Medicine
Roy S. Herbst, director of the Dartmouth Cancer Center and a professor of microbiology and immunology and of medicine at Geisel School of Medicine, has been elected to the National Academy of Medicine. One of the highest honors in the fields of health and medicine, NAM recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Opinion: Doctor, Do You Deprescribe?—Valley News
Read article–Diane Roston, a clinical assistant professor of psychiatry, writes about the growing practice of deprescribing medications and the importance ofindividualized treatment decisions. “As we acknowledge the potential harm of medication, we must also recognize the potential good,” Roston writes, emphasizing the need to balance medication benefits, withdrawal risks, and patient preferences.
The Flu Is Early This Year, So NH Doctors Say Now’s the Time to Get Vaccinated—New Hampshire Public Radio
Read article—Gabriela Andujar Vazquez, an assistant professor of medicine, is quoted in an article about the early onset of flu season in New Hampshire. “Get it now so you can get those two weeks in of building up that immunity from the vaccine,” Andujar Vazquez said, urging people to get vaccinated ahead of an expected rise in cases.
Study: Most Daily Cannabis Consumers Don’t Meet Criteria for “Moderate” or “Severe” Cannabis Use Disorder—NORML
Read article—A study conducted by Dartmouth researchers found that most daily cannabis consumers did not meet the diagnostic criteria for moderate or severe cannabis use disorder, despite reporting an average consumption of more than 200 mg of THC per day.
AI In Healthcare: From Fighting Epidemics To Family Doctors—Euronews
Read article—Thomas Thesen, a professor of medical education, is featured in an article examining AI’s potential to improve healthcare and its limitations in clinical decision-making and medical education. “They are extremely good at recognizing patterns, but they are really bad at explaining to us what those patterns actually are,” Thesen said, emphasizing the need for transparency and independent learning.
DNA Recording System Reveals How A Single Cell Becomes A Body—ScienceDaily
Read article—A study led by Chengxiang Qiu, an assistant professor of molecular and systems biology, is highlighted for using DNA recording technology to trace the development of a mouse embryo from its first two cells through the formation of organs and tissues. The findings reveal how different cell types develop on distinct timelines.
‘DNA Typewriter’ Records Cells’ History in Developing Mouse Embryo—Phys.org
Read article—A study led by Chengxiang Qiu, an assistant professor of molecular and systems biology, is highlighted for using DNA Typewriter technology to trace cell lineages throughout early mouse embryonic development. The research reconstructed the developmental histories of approximately 1.3 million cells, offering new insights into how cells specialize. (Similar coverage in Scienmag.)

